Zhang, Tianqian
GlaxoSmithKline (United States)
2 papers on CoChatORCID 0000-0002-7952-5728
Most cited papers
- Verified
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
Liu, L., Mayes, P. A., Eastman, S., Shi, H., Yadavilli, S., Zhang, T., Yang, J., Seestaller-Wehr, L., Zhang, S.-Y., Hopson, C., et al. (2015) · Clinical Cancer Research
Melanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers
Cited by 446
- Verified
Nippocystatin, a Cysteine Protease Inhibitor from Nippostrongylus brasiliensis, Inhibits Antigen Processing and Modulates Antigen-Specific Immune Response
Dainichi, T., Maekawa, Y., Ishii, K., Zhang, T., Nashed, B. F., Sakai, T., Takashima, M., & Himeno, K. (2001) · Infection and Immunity
Parasites and Host InteractionsHelminth infection and control
Cited by 125
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free